ANGIOGENESIS AND INVASION
H. Abuhusain, A. Matin, Q. Qiao, Huming Shen et autres
INTRODUCTION: Recently, anti-angiogenic therapies have moved into the forefront of GBM targeted therapies, especially following the success of anti-VEGF treatment in increasing progression-free survival and quality of life for patients.However, with the recurrence of GBMs, anti-VEGF treatment seems insufficient at blocking glioma …
us, jp, au (code pays fourni par la source)